# Halozyme Therapeutics, Inc.: filings

HALO · Nasdaq · CIK 1159036 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/halo.md) · [Financials](/companies/halo/financials.md) · [Filings](/companies/halo/filings.md) · [Insiders](/companies/halo/insiders.md)

## Reports and events: 315 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 533, 8-K 211, 144 76, 10-Q 53, SC 13G/A 49, 3 34, 10-K 18, DEF 14A 18, DEFA14A 16, SC 13G 12, UPLOAD 12, 424B5 10, CORRESP 10, SC 13D/A 10, S-8 8, 4/A 5, ARS 5, 8-K/A 4, CT ORDER 4, PRE 14A 3, SCHEDULE 13G/A 3, SC TO-C 3, SC TO-T/A 3, EFFECT 2, S-3ASR 2, S-8 POS 2, 10-Q/A 1, 5 1, S-3 1, SCHEDULE 13G 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 20:20 ET | [8-K](/filings/0001159036-26-000128.md) | 5.02 Departure or appointment of officers or directors | 0001159036-26-000128 |
| 2026-09-22 | 20:41 ET | [8-K](/filings/0001193125-26-398015.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-398015 |
| 2026-09-18 | 12:23 ET | [8-K](/filings/0001159036-26-000126.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-26-000126 |
| 2026-09-16 | 20:32 ET | [8-K](/filings/0001159036-26-000121.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-26-000121 |
| 2026-08-18 | 20:04 ET | [8-K](/filings/0001159036-26-000106.md) | 5.02 Departure or appointment of officers or directors | 0001159036-26-000106 |
| 2026-08-06 | 20:11 ET | [10-Q](/filings/0001159036-26-000104.md) | Quarterly report, period 2026-06-30 | 0001159036-26-000104 |
| 2026-08-06 | 20:08 ET | [8-K](/filings/0001159036-26-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000103 |
| 2026-07-02 | 20:10 ET | [8-K](/filings/0001159036-26-000088.md) | 5.02 Departure or appointment of officers or directors | 0001159036-26-000088 |
| 2026-05-11 | 20:09 ET | [10-Q](/filings/0001159036-26-000068.md) | Quarterly report, period 2026-03-31 | 0001159036-26-000068 |
| 2026-05-11 | 20:06 ET | [8-K](/filings/0001159036-26-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000067 |
| 2026-05-07 | 20:16 ET | [8-K](/filings/0001159036-26-000057.md) | 5.07 Shareholder vote results | 0001159036-26-000057 |
| 2026-04-30 | 12:12 ET | [8-K](/filings/0001159036-26-000053.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001159036-26-000053 |
| 2026-04-24 | 20:06 ET | [8-K](/filings/0001159036-26-000051.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001159036-26-000051 |
| 2026-03-23 | 20:11 ET | [DEF 14A](/filings/0001159036-26-000041.md) | Proxy statement, period 2025-12-31 | 0001159036-26-000041 |
| 2026-03-12 | 12:32 ET | [8-K](/filings/0001159036-26-000035.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001159036-26-000035 |
| 2026-02-17 | 21:08 ET | [10-K](/filings/0001159036-26-000024.md) | Annual report, period 2025-12-31 | 0001159036-26-000024 |
| 2026-02-17 | 21:04 ET | [8-K](/filings/0001159036-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000023 |
| 2026-01-28 | 11:40 ET | [8-K](/filings/0001159036-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000011 |
| 2025-12-09 | 21:45 ET | [8-K](/filings/0001159036-25-000070.md) | 5.02 Departure or appointment of officers or directors | 0001159036-25-000070 |
| 2025-12-08 | 22:20 ET | [8-K](/filings/0001159036-25-000068.md) | 5.02 Departure or appointment of officers or directors | 0001159036-25-000068 |
| 2025-11-24 | 21:06 ET | [8-K](/filings/0001159036-25-000061.md) | 5.02 Departure or appointment of officers or directors | 0001159036-25-000061 |
| 2025-11-12 | 22:17 ET | [8-K](/filings/0001193125-25-277988.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-277988 |
| 2025-11-07 | 13:02 ET | [8-K](/filings/0001159036-25-000049.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-25-000049 |
| 2025-11-05 | 21:59 ET | [8-K](/filings/0001159036-25-000047.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-25-000047 |
| 2025-11-03 | 21:13 ET | [10-Q](/filings/0001159036-25-000045.md) | Quarterly report, period 2025-09-30 | 0001159036-25-000045 |
| 2025-11-03 | 21:07 ET | [8-K](/filings/0001159036-25-000044.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001159036-25-000044 |
| 2025-10-14 | 10:45 ET | [8-K](/filings/0001159036-25-000039.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001159036-25-000039 |
| 2025-10-06 | 20:58 ET | [8-K](/filings/0001159036-25-000036.md) | 5.02 Departure or appointment of officers or directors | 0001159036-25-000036 |
| 2025-10-03 | 20:51 ET | [8-K](/filings/0001193125-25-230348.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-230348 |
| 2025-10-01 | 11:06 ET | [8-K](/filings/0001193125-25-225853.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-225853 |
| 2025-08-05 | 20:09 ET | [10-Q](/filings/0001159036-25-000034.md) | Quarterly report, period 2025-06-30 | 0001159036-25-000034 |
| 2025-08-05 | 20:06 ET | [8-K](/filings/0001159036-25-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000033 |
| 2025-05-06 | 20:08 ET | [10-Q](/filings/0001159036-25-000026.md) | Quarterly report, period 2025-03-31 | 0001159036-25-000026 |
| 2025-05-06 | 20:06 ET | [8-K](/filings/0001159036-25-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000025 |
| 2025-05-02 | 20:07 ET | [8-K](/filings/0001159036-25-000022.md) | 5.07 Shareholder vote results | 0001159036-25-000022 |
| 2025-03-21 | 20:03 ET | [8-K](/filings/0001159036-25-000020.md) | 5.02 Departure or appointment of officers or directors | 0001159036-25-000020 |
| 2025-03-18 | 20:10 ET | [DEF 14A](/filings/0001159036-25-000016.md) | Proxy statement, period 2024-12-31 | 0001159036-25-000016 |
| 2025-02-18 | 21:17 ET | [10-K](/filings/0001159036-25-000010.md) | Annual report, period 2024-12-31 | 0001159036-25-000010 |
| 2025-02-18 | 21:06 ET | [8-K](/filings/0001159036-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000008 |
| 2025-02-13 | 21:30 ET | [8-K](/filings/0001159036-25-000005.md) | 5.02 Departure or appointment of officers or directors | 0001159036-25-000005 |
| 2025-01-08 | 13:00 ET | [8-K](/filings/0001159036-25-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000003 |
| 2024-10-31 | 20:07 ET | [10-Q](/filings/0001159036-24-000050.md) | Quarterly report, period 2024-09-30 | 0001159036-24-000050 |
| 2024-10-31 | 20:05 ET | [8-K](/filings/0001159036-24-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-24-000049 |
| 2024-08-06 | 20:07 ET | [10-Q](/filings/0001159036-24-000044.md) | Quarterly report, period 2024-06-30 | 0001159036-24-000044 |
| 2024-08-06 | 20:03 ET | [8-K](/filings/0001159036-24-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-24-000043 |
| 2024-05-07 | 20:09 ET | [10-Q](/filings/0001159036-24-000037.md) | Quarterly report, period 2024-03-31 | 0001159036-24-000037 |
| 2024-05-07 | 20:05 ET | [8-K](/filings/0001159036-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-24-000036 |
| 2024-04-26 | 20:22 ET | [8-K](/filings/0001159036-24-000031.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001159036-24-000031 |
| 2024-03-15 | 20:06 ET | [DEF 14A](/filings/0001159036-24-000024.md) | Proxy statement, period 2023-12-31 | 0001159036-24-000024 |
| 2024-02-20 | 21:07 ET | [10-K](/filings/0001159036-24-000008.md) | Annual report, period 2023-12-31 | 0001159036-24-000008 |

Page 1 of 7. [Older](/companies/halo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.